SARS‐CoV‐2‐specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID‐19 vaccination

por Jarisch, Andrea, Wiercinska, Eliza, Daqiq‐Mirdad, Shabnam, Hellstern, Helen, Ajib, Salem, Cremer, Anjali, Nguyen, Ngoc Thien Thu, Dukat, Alexandra, Ullrich, Evelyn, Ciesek, Sandra, Chow, Kai‐Uwe, Serve, Hubert, Seifried, Erhard, Bader, Peter, Bonig, Halvard, Bug, Gesine
Publicado 2022

Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia

por Kutsch, Nadine, Pallasch, Christian, Decker, Thomas, Hebart, Holger, Chow, Kai Uwe, Graeven, Ullrich, Kisro, Jens, Kroeber, Alexander, Tausch, Eugen, Fischer, Kirsten, Fink, Anna-Maria, Wendtner, Clemens-Martin, Ritgen, Matthias, Stilgenbauer, Stephan, Zhang, Danjie, Li, Biao, Jürgensmeier, Juliane M., Rajakumaraswamy, Nishanthan, Bhargava, Pankaj, Hallek, Michael, Eichhorst, Barbara
Publicado 2022